← brief for 2026-08-26 · Slowing decline

GLP-1 receptor agonists are associated with lower kidney cancer risk after metabolic bariatric surgery.

Article C Peer reviewed Observational

Key takeaways

People who took GLP-1 drugs after weight-loss surgery had lower kidney cancer risk than those on other diabetes medicines, but this study only shows a link — it cannot prove the drug caused the lower risk. The data came from past records, not a planned experiment.

Who did this work

Hernández-Pérez JG · Abdelgadir O · Albayyaa M · Ernest DK · Chen J · DeSantis SM · Hong AS · Cowell LG · Almandoz JP · Messiah SE · Lopez DS

Source

Article · PubMed, the drug frontier · 2026 Aug 26
https://pubmed.ncbi.nlm.nih.gov/42644757/